Cargando…
The Undervalued Avenue to Reinstate Tumor Suppressor Functionality of the p53 Protein Family for Improved Cancer Therapy-Drug Repurposing
SIMPLE SUMMARY: Tackling the current dilemmas of cancer care, namely, financial and systemic burdens, is challenging. One way to address this challenge is to apply drug repurposing. Drug repurposing uses existing drugs for new medical indications like oncology. In drug repurposing, all clinical data...
Autor principal: | Zawacka-Pankau, Joanna E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563196/ https://www.ncbi.nlm.nih.gov/pubmed/32971841 http://dx.doi.org/10.3390/cancers12092717 |
Ejemplares similares
-
The Role of p53 Family in Cancer
por: Zawacka-Pankau, Joanna E.
Publicado: (2022) -
The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer
por: Fregni, Matilde, et al.
Publicado: (2022) -
The p53/MDM2/MDMX-targeted therapies—a clinical synopsis
por: Jiang, Liren, et al.
Publicado: (2020) -
Activation of TAp73 and inhibition of TrxR by Verteporfin for improved cancer therapy in TP53 mutant pancreatic tumors
por: Acedo, Pilar, et al.
Publicado: (2019) -
Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells
por: Jiang, Liren, et al.
Publicado: (2019)